Related Experiment Videos
[Relationship between asthma and activated T-lymphocytes and interleukin-4]
1Respiratory Department, Changhai Hospital, Second Military Medical University, Shanghai.
Zhonghua Nei Ke Za Zhi
|January 1, 1997
Summary
Activated T-lymphocytes and interleukin-4 (IL-4) are key players in asthma development. Steroid treatment for asthma works partly by reducing these inflammatory markers.
Area of Science:
- Immunology
- Respiratory Medicine
Context:
- Asthma pathogenesis involves complex immune responses.
- T-lymphocytes and cytokines like IL-4 are implicated in asthma.
- Biomarkers such as sIL-2R and IgE are relevant to asthma severity.
Purpose:
- To investigate the role of activated T-lymphocytes and IL-4 in asthma pathogenesis.
- To measure serum sIL-2R and IgE, and IL-4 production in asthmatic patients.
- To evaluate the effect of dexamethasone on these markers.
Summary:
- Asthmatic patients exhibited significantly higher serum sIL-2R and IL-4 levels compared to controls.
- Elevated IL-4 correlated positively with total IgE and negatively with FEV1%.
- Dexamethasone treatment led to a significant reduction in sIL-2R and IL-4 levels.
Impact:
- Activated T-lymphocytes and IL-4 are crucial in asthma pathogenesis.
- Steroid therapy for asthma partially functions by inhibiting T-lymphocyte activation and IL-4 release.
- Findings support targeted immunomodulatory therapies for asthma.